Related Experiment Video
Updated: May 29, 2026
10:25
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
Hemostasis research in India: past, present, and future
Kanjaksha Ghosh1, Kinjalka Ghosh, Shrimati Shetty
1National Institute of Immunohaematology, KEM Hospital Campus, Mumbai, India. kanjakshaghosh@hotmail.com
Summary
Hemostasis research in India, a young specialty, has a rich history. Current research focuses on prenatal diagnostics, mutation detection, and low-cost treatments for bleeding disorders like hemophilia.
Area of Science:
- Hematology
- Medical Research
Background:
- Hemostasis research in India has evolved significantly over the past 60 years.
- Key institutions like AIIMS Delhi and CMC Vellore have historically contributed to understanding bleeding disorders.
Observation:
- While some historical centers are less active, current research hubs include the Institute of Immunohaematology, CMC Vellore, and AIIMS Delhi.
- Research is shifting towards advanced areas like prenatal diagnostics and genetic mutation detection.
Findings:
- Developing cost-effective management strategies for hemophilia and other bleeding disorders is a key focus.
- Prevalence studies and case descriptions remain important, alongside new technological advancements.
Implications:
- The growth of corporate hospitals and structured postgraduate programs will likely accelerate future advancements in hemostasis research in India.
- These developments promise improved diagnostics and treatments for bleeding disorders nationwide.
Related Concept Videos
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...